Dr. Rita Nahta

Assistant Professor of Pharmaceutical Sciences


  • B.S., Chemistry, University of North Carolina at Chapel Hill
  • PhD, Pathology, Duke University
  • Postdoctoral Research, Harvard Medical School and Massachusetts General Hospital Cancer Center
  • Postdoctoral Research, MD Anderson Cancer Center


Molecular and Cellular Cancer Biology: My research team investigates the molecular mechanisms underlying cancer progression and the response to targeted cancer therapies. Our long-term objective is to identify new pharmacological targets and drug combinations for advanced and drug-refractory cancers. We have a primary interest in understanding mechanisms of drug resistance and disease progression in breast cancer. Current projects include identifying mechanisms of resistance to kinase inhibitors, signaling networks driving cancer cell invasion, and the mechanistic basis for combining targeted cancer therapies.


  • PHA533 Musculoskeletal Disorders
  • PHA844 Scientific Writing
  • PHA899 Doctoral Research


Contact Dr. Nahta